Question
· Jun 11, 2020

Ensemble ORU^R01 Message Error

Hi,

I am getting following message in Ensemble.

HL7 ORU_R01 Message - Id = 3672630, DocType = '2.4:ORU_R01', Message Type Category = '2.4'
'Unsolicited transmission of an observation message - Unsolicited transmission of an observation message', 26 Segments
Build Map Status = 'ERROR <EnsEDI>ErrMapRequired: Missing required PIDgrpgrp(1).ORCgrp(1).OBR element at segment 2 ( PID)'
'ERROR <EnsEDI>ErrMapRequired: Missing required PIDgrpgrp(1).ORCgrp(1) element at segment 2'
'ERROR <EnsEDI>ErrMapRequired: Missing required PIDgrpgrp(1) element at segment 2'
'ERROR <EnsEDI>ErrMapSegUnrecog: Unrecognized Segment 2:' PID' found after segment 1 (MSH)'

Message is -

MSH|^~\&|SLIMS||SLIMS_PROD||20200608130341||ORU^R01|12345|P|2.4|1
PID||5520005629|0102163||JINDAL^ASHOKI KR^^||19490901|M
PV1||I|SWB RESPIRATORY HDU^RM-1382^RHDU-06
ORC|SC|5520005629|5520005629||CM||||||||||||||
OBR|1|5520005629|5520005629|M991^BacT/Alert aerobic culture ( Blood ) - L^L|||20200608125500|||||||20200121000000
OBX|1|ST|M0196^Comments^L||Bacterial growth of doubtful significance.|||L|||P
OBX|2|ST|M0922^LEFT PERIPHERAL SAMPLE^L||Negative|||L|||P
OBX|3|ST|M0923^RIGHT PERIPHERAL SAMPLE^L||Positive|||L|||P
OBX|4|ST|M0925^DIALYSIS CATHETER SAMPLE^L||Positive|||L|||P
OBX|5|TX|M1678^Organism^L|1|E. coli|||L|||P
OBX|6|TX|TET^Tetracycline^L|1|Moderate Sensitive|||L|||P
OBX|7|TX|CAR^Carbapenemase^L|2|Sensitive|||L|||P
OBX|8|TX|CEF^Cefepime^L|3|Moderate Sensitive|||L|||P
OBX|9|TX|CEF^Cefazolin^L|4|Resistant|||L|||P
OBX|10|TX|COL^Colistin^L|5|Moderate Sensitive|||L|||P
OBX|11|TX|ERT^Ertapenem^L|6|Resistant|||L|||P
OBX|12|TX|ESB^ESBL^L|7|Moderate Sensitive|||L|||P
OBX|13|TX|M2009^Organism^L|2|Streptococcus salivarius|||L|||P
OBX|14|TX|TET^Tetracycline^L|1|Sensitive|||L|||P
OBX|15|TX|CAR^Carbapenemase^L|2|Moderate Sensitive|||L|||P
OBX|16|TX|CEF^Cefepime^L|3|Sensitive|||L|||P
OBX|17|TX|CEF^Cefazolin^L|4|Resistant|||L|||P
OBX|18|TX|COL^Colistin^L|5|Resistant|||L|||P

Please help.

Thanks,

Vinay Purohit
 

Discussion (5)1
Log in or sign up to continue